NAIROBI, Nov. 24 (Xinhua) -- Thirteen African countries on Tuesday announced a collaborative venture with international research networks to implement clinical trials aimed at enhancing treatment of mild COVID-19 cases.
The Drugs for Neglected Diseases Initiative (DNDi), an international drugs research entity, said in a statement released in Nairobi that the clinical trials will be conducted in 19 sites to help identify therapeutics that could prevent COVID-19 patients from reaching critical stages.
Subscribe to The Star Yearly Premium Plan for 30% off
Cancel anytime. Ad-free. Full access to Web and App.
Monthly Plan
RM 13.90/month
RM 9.73/month
Billed as RM 9.73 for the 1st month, RM 13.90 thereafter.
Annual Plan
RM 12.39/month
RM 8.63/month
Billed as RM 103.60 for the 1st year, RM 148 thereafter.